๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-09-16

Safety and Efficacy of FETO in CDH Phase III (NCT07187206)

๐ŸŸข Recruiting Phase3 โš™๏ธ Medical Device Protocol Sponsor: Children's Hospital Medical Center, Cincinnati

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group

Who can join: Review the eligibility criteria below.

Location: Cincinnati Children's Hospital Medical Center (CCHMC) โ€” Cincinnati, Ohio

Age range: 18 Years to 50 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Cincinnati Children's Hospital Medical Center (CCHMC) โ€” Cincinnati, Ohio

๐Ÿ“ž Contact the Study Coordinator

Phone: (513) 636-6259

Email: Foong-Yen.Lim@cchmc.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—